1-5 of 5
Joe W. Gray
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer

Free
Saima Hassan, Amanda Esch, Tiera Liby, Joe W. Gray, Laura M. Heiser
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (12): 2892–2901.
https://doi.org/10.1158/1535-7163.MCT-17-0170
Published: 03 December 2017
View article titled, Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer
Open the PDF for Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform

Free
Jingga Morry, Worapol Ngamcherdtrakul, Shenda Gu, Moataz Reda, David J. Castro, Thanapon Sangvanich, Joe W. Gray, Wassana Yantasee
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (4): 763–772.
https://doi.org/10.1158/1535-7163.MCT-16-0644
Published: 02 April 2017
View article titled, Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform
Open the PDF for Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform in another window
Includes: Supplementary data
Journal Articles

Abstract A179: Synergistic interactions of Lapatinib and an AKT inhibitor in HER2 positive breast cancer cell lines depends on PI3K pathway status

Free
James Korkola, Nora Bayani, Brian Cooper, Wen‐Lin Kuo, Jessica Billig, Saffiyah Ziyad, Heidi Feiler, Paul Spellman, Richard Wooster, Joe W. Gray
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A179.
https://doi.org/10.1158/1535-7163.TARG-09-A179
Published: 10 December 2009
View article titled, Abstract A179: Synergistic interactions of Lapatinib and an AKT inhibitor in HER2 positive breast cancer cell lines depends on PI3K pathway status
Journal Articles

Asparagine synthetase as a causal, predictive biomarker for l-asparaginase activity in ovarian cancer cells

Free
Philip L. Lorenzi, William C. Reinhold, Martina Rudelius, Michele Gunsior, Uma Shankavaram, Kimberly J. Bussey, Uwe Scherf, Gabriel S. Eichler, Scott E. Martin, Koei Chin, Joe W. Gray, Elise C. Kohn, Ivan D. Horak, Daniel D. Von Hoff, Mark Raffeld, Paul K. Goldsmith, Natasha J. Caplen, John N. Weinstein
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (11): 2613–2623.
https://doi.org/10.1158/1535-7163.MCT-06-0447
Published: 22 November 2006
View article titled, Asparagine synthetase as a causal, predictive biomarker for l-asparaginase activity in ovarian cancer cells
Open the PDF for Asparagine synthetase as a causal, predictive biomarker for l-asparaginase activity in ovarian cancer cells in another window
Journal Articles

Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel

Free
Kimberly J. Bussey, Koei Chin, Samir Lababidi, Mark Reimers, William C. Reinhold, Wen-Lin Kuo, Fuad Gwadry, Ajay, Hosein Kouros-Mehr, Jane Fridlyand, Ajay Jain, Colin Collins, Satoshi Nishizuka, Giovanni Tonon, Anna Roschke, Kristen Gehlhaus, Ilan Kirsch, Dominic A. Scudiero, Joe W. Gray, John N. Weinstein
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (4): 853–867.
https://doi.org/10.1158/1535-7163.MCT-05-0155
Published: 28 April 2006
View article titled, Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel
Open the PDF for Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel in another window